Great Lakes Advisors, LLC Repligen Corp Transaction History

Great Lakes Advisors, LLC

  • $10.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$170.78 - $208.42 $19.8 Million - $24.2 Million
-116,178 Reduced 94.81%
6,362 $1.17 Million
Q4 2023

Feb 08, 2024
SELL
$114.17 - $185.35 $120,791 - $196,100
-1,058 Reduced 0.86%
122,540 $22 Million
Q3 2023

Nov 07, 2023
BUY
$138.78 - $176.51 $17.2 Million - $21.8 Million
123,598 New
123,598 $19.7 Million

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
53.9M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.26B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email